Los Angeles 2017

May 5-10, 2017

Drug Delivery in the Crossfire: New Approaches to Reduce Reliance on Drops

Supported By:

 

Los Angeles

Sunday, May 7, 2017

City/State/Country: Los Angeles, CA USA
Venue: JW Marriott
Room Location: Platinum Ballroom D-J
Registration: 5:00 PM - 5:15 PM
Program: 5:15 PM - 6:15 PM

Faculty

Panel:
Edward J. Holland, MD
Richard L. Lindstrom, MD
John Berdahl, MD
Terry Kim, MD

Preliminary Program

Join the live studio audience as we record a video roundtable with leading experts on new approaches for optimizing drug delivery

 

Target Audience
This educational activity is intended for ophthalmologists.

Educational Objectives
Ophthalmologists attending this meeting will:

  • Cite the reasons for and consequences of poor compliance with topical therapy
  • Identify strategies and new technologies for reducing the number and frequency of topical drops after cataract surgery

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society of Cataract and Refractive Surgery (ASCRS) and EyeWorld news magazine. ASCRS is accredited by the ACCME to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality, and scientific integrity of this CME activity.

Designation Statement
The American Society of Cataract and Refractive Surgery designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™
Physicians should claim only credit commensurate with the extent of their participation in the activity. 
Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credit™

Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits.

Notice of Off-Label Use Presentations
This program may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he/she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products, or techniques presented.

ADA/Special Accommodations
ASCRS fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. ASCRS also requires ADA compliance from its contracted vendors and facilities. Any participant in this educational program who requires special accommodation or services should contact an ASCRS or EyeWorld staff member onsite.